Session: OS-22B
Parallel Session B: Clinical

Jonathan Rowlinson (The University of Nottingham), Maria de los Angeles Estevez-Cebrero (The University of Nottingham), Anbarasu Lourdusamy (The University of Nottingham), Ruman Rahman (The University of Nottingham), Stuart Smith (The University of Nottingham)

Susan Short (University of Leeds), Brian Hutton (University College London), Luisa Ottobrini (University of Milan), Irene De Francesco (University College London), Carlo Fiorini (Politecnico di Milano)

Angelo Pichierri (Southmead Hospital - North Bristol NHS Trust), Venkat Iyer (Southmead Hospital - North Bristol NHS Trust)

Garth Cruickshank (University of Birmingham and Queen Elizabeth Hospital), Desire Ngoga (University of Birmingham and Queen Elizabeth Hospital), Allah Detta (University of Birmingham and Queen Elizabeth Hospital), Andy Lewis (Biocompatibles, Farnham, Surrey), Rebecca Holden (Bio), Olufawe Fayaye (University of Birmingham and Queen Elizabeth Hospital)

Matt Williams (Imperial College Healthcare Trust), Helen Cross (University College London), Michael D Jenkinson (University of Liverpool), Kirsty Martin (University of Liverpool), Susan Wood (Matthew's Friends), Adrienne C. Scheck (Barrow Neurological Institute), Nelofer Syed (Imperial College London), Kevin O'Neill (Imperial College Healthcare Trust), Katie Sheen (Astro Fund), Catherine Zabilowicz (Matthew's Friends), Kieran Breen (Brain Tumour Research), Kathy Oliver (International Brain Tumour Alliance), Emma Williams (Matthew's Friends), Mike Johnson (Imperial College), Wendy Fulcher (Brain Tumour Research Campaign)